Initially identified in the setting of tissue damage occurring in GVHD, STAT1-mediated regulation of ISC Myc was validated in non-transplant ex vivo organoid culture models, and this immune-mediated regulation of ISCs may have relevance for tissue responses to lymphocytes and inflammation in other settings as well. Here, STAT1 is linked to graft versus host disease.